Skip to main content
Reduced Toxicity Conditioning for Non-Malignant Hematopoietic Cell Transplants.
Calming the storm in HLH.
In ALD, I feel the need for speed.
Single-cell RNA-Seq of follicular lymphoma reveals malignant B-cell types and coexpression of T-cell immune checkpoints.
Phase I Study of the Selinexor in Relapsed/Refractory Childhood Acute Leukemia.
Germline GAB2 Mutations in Childhood Acute Lymphoblastic Leukemia.
DNA Methylation Subgroups in Juvenile Myelomonocytic Leukemia: An International Collaborative Analysis and Development of a Common Diagnostic Platform.
SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.
B-cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation.
Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia.